Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1219758C reveals a scalable inclusion resolution method for di-tert-butyl thiosulfinate, offering dual-configuration access and significant cost reduction potential.
Novel in-situ quenching method for p-bromophenylboronic acid synthesis improves yield and reduces cryogenic costs for pharmaceutical intermediates.
Novel four-step route for spiro-piperidine intermediates. High yield, scalable process reducing raw material costs for pharma manufacturing.
Patent CN113582847B reveals high-purity iodobenzoic acid synthesis. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.
Patent CN102827893A details a novel enzymatic transesterification process for high-purity aryl acetic acid L-ascorbyl esters, offering zero wastewater and superior yield.
Patent CN113736842B reveals high-purity TUDCA production via multi-cell catalysis. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN107129444A reveals a novel purification strategy for Eluxadoline intermediates, ensuring >99% purity and robust commercial scalability for global supply chains.
Patent CN120329198A details a scalable salicylic acid route for 2-fluoro-3-nitrobenzoic acid, offering superior purity and cost efficiency for global supply chains.
Patent CN106701882A details a novel chemo-enzymatic route for UDCA production offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Novel Pd/C water-based method for indole-2-carboxylic acid. Reduces cost, improves safety, ensures high purity for pharmaceutical supply chains.
Patent CN104402803A details high-yield L-high proline synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN117603169B reveals a novel route for pilocarpine intermediates. Achieve higher yields and safer scale-up for pharmaceutical manufacturing supply chains.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Novel resin-catalyzed synthesis ensures high purity gallic acid esters. Cost-effective manufacturing and reliable supply chain for global food additive procurement.
Novel palladium-free synthesis of 3-methylbenzo[d]oxazol-2(3H)-one-5-boronic acid pinacol ester. High purity >99%, total yield >81%, cost-effective API intermediate manufacturing.
Patent CN111170847B reveals a cyanide-free route for Drotaverine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Patent CN103408573B reveals novel NHC-catalyzed boration. Achieve cost reduction in API intermediate manufacturing with high-purity boronic acid derivatives.
Novel low-temperature halogenated solvent process for high-purity imidazole ester. Reduces cost and eliminates chromatography for reliable pharmaceutical intermediate supply.
Patent CN107793325A reveals a green boric acid catalyzed route for synthetic capsaicin, offering high purity and reduced environmental impact for supply chains.
Novel patent CN110128347A enables high-purity indazole intermediate production with scalable carbonylation technology for reliable pharmaceutical supply chains.